Figure 3. Meta-analysis of the Efficacy of Paromomycin Compared with Pentavalent Antimony Compounds*†.

Abbreviations: CI, confidence interval; CL, cutaneous leishmaniasis; MA, meglumine antimoniate; MBCL, methylbenzethonium chloride; PR, paromomycin; RR, risk ratio; SB, sodium stibogluconate. * Pooled RRs and 95% CIs of clinical cure were calculated using an inverse-variance weighted random-effects model and displayed in diamonds in the figure. The I² statistic describes the percentage of total variation across the studies that is attributable to heterogeneity rather than chance. † Parenteral antimony compounds include parenteral MA and parenteral SB.